 
  
    
           News
           
International team of scientists launch largest-ever study tracking chikungunya burden in East Africa
                 OSLO/ OXFORD, UK, 12 Dec 2024—A team of scientists in the UK, Kenya and Tanzania will soon find out the extent to which chikungunya, a debilitating mosquito-borne disease causing large outbreaks in Asia and South America, is also affecting countries in East Africa. Led by the University of Oxford, the scientists are set to investigate […]           
 
           
                Read More
           
     
  
    
           News
           
Promising human Rift Valley fever vaccine to enter Phase II clinical trials in Kenya
                 New CEPI-funded trial to launch in Kenya – the first ever Phase II trial of a Rift Valley fever vaccine in an endemic country Earlier vaccine studies show positive safety data, and generation of an immune response Rift Valley fever is a mosquito-borne disease affecting people and animals across Africa OSLO/NAIROBI, October 13 – A […]           
 
           
                Read More
           
     
  
    
           News
           
Revolutionizing Care: Advancements in Sickle Cell Disease Research
                 The fight against sickle cell disease (SCD) has seen significant progress thanks to the ongoing research conducted by KEMRI-Wellcome Trust Research Programme (KWTRP) in collaboration with Kilifi County Teaching and Referral Hospital (KCTRH) through the joint management of the pediatric sickle cell clinic. The clinic which also serves neighbouring counties provides diagnosis (for children) and […]           
 
           
                Read More
           
     
  
    
           News
           
KWTRP 2023 Annual Report
                 In our 2023 Annual Report, we highlight our progress in science, capacity development, & impact. We also celebrate our people, highlighting individual & collective achievements.           
 
           
                Read More
           
     
															 
  
     
  
     
  
     
  
     
  
    